This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.

How to use DOLALGIAL CLONIXINE LYSINE 125 mg FILM-COATED TABLETS

Introduction

PACKAGE LEAFLET: INFORMATION FOR THE USER

Dolalgial clonixine lysine 125mg coated tablets

Clonixine lysine

Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.

Keep this leaflet, you may need to read it again.- If you need advice or more information, consult your pharmacist.- If you experience side effects, consult your doctor or pharmacist, even if they are not listed in this leaflet. See section 4.
You should consult a doctor if it worsens or does not improve after 10 days.

Contents of the package leaflet:

What is Dolalgial and what is it used for
What you need to know before taking Dolalgial
How to take Dolalgial
Possible side effects
Storage of Dolalgial
Package contents and additional information

1. What is Dolalgial and what is it used for

Dolalgial is a pain-relieving medication that belongs to a group of medications called non-steroidal anti-inflammatory drugs. It is an effective medication for reducing pain.

Dolalgial is indicated for the symptomatic relief of mild to moderate pain in adults, such as headache, dental, menstrual, muscle (contractures) or back (lumbago) pain.

2. What you need to know before taking Dolalgial

Do not take Dolalgial

if you are allergic (hypersensitive) to clonixine lysine or any of the other components of Dolalgial.
if you have an active stomach ulcer.
if you have blood cell formation disorders.
if you have severe kidney failure.
if you have a tendency to suffer from digestive bleeding.
if you are pregnant or breastfeeding (see the section on pregnancy and breastfeeding).

Warnings and precautions

Consult your doctor or pharmacist before taking Dolalgial if:

you have a history of gastrointestinal disorders, stomach ulcers, or inflammatory bowel disease, especially if you are taking clonixine lysine at high doses (4 tablets a day).
you have mild to moderate kidney function impairment.
you have any heart condition.
you have a history of hypersensitivity (allergy) to non-steroidal anti-inflammatory drugs, history of asthma attacks, as well as skin eruptions or acute rhinitis.
you are taking non-steroidal anti-inflammatory drugs at very high doses.
you have liver function impairment.
clonixine lysine may cause difficulty in becoming pregnant. You should inform your doctor if you are planning to become pregnant or are having trouble becoming pregnant.

Consult your doctor, even if any of the above circumstances have occurred to you in the past.

Children and adolescents

Do not use in children under 18 years of age without consulting a doctor.

Using Dolalgial with other medications

Tell your doctor or pharmacist if you are taking or have recently taken any other medications, including those obtained without a prescription.

Certain medications may interact with Dolalgial, and it may be necessary to change the dose or discontinue treatment with one of the medications. Therefore, do not use them without consulting your doctor.

This is especially important in the case of:

Lithium salts (used in the treatment of depression).
Antihypertensives (medications used to treat high blood pressure).
Diuretics (medications that increase urine production).
Non-steroidal anti-inflammatory drugs.
Glucocorticoids (medications used to treat inflammation).
Ticlopidine, heparin, and thrombolytics (medications that prevent blood clot formation).
Methotrexate (used to treat cancer and rheumatoid arthritis).

Using Dolalgial with food, drinks, and alcohol

Do not take with alcohol, as it increases the risk of stomach ulcers.

Take it preferably with meals.

Pregnancy and breastfeeding

Consult your doctor or pharmacist before taking any medication.

Pregnancy:

Do not take Dolalgial during the first and second trimesters of pregnancy.

This medication is contraindicated during the third trimester.

IMPORTANT FOR WOMEN:

If you are pregnant or think you may be pregnant, consult your doctor before taking this medication. Taking medications during pregnancy can be hazardous to the embryo or fetus and should be monitored by your doctor.

Breastfeeding:

It is not recommended to administer this medication to breastfeeding women, as clonixine lysine passes into breast milk.

Driving and using machines

During treatment, avoid situations that require a special state of alertness, such as driving vehicles or operating hazardous machinery, as clonixine lysine may decrease reaction capacity. Therefore, try not to perform tasks that require special attention until you know how you tolerate the medication.

3. How to take Dolalgial

Follow your doctor's instructions for taking Dolalgial exactly. Consult your doctor or pharmacist if you have any doubts.

Dolalgial is administered orally. The tablets should be swallowed whole without being broken or chewed, accompanied by a glass of liquid, preferably water. Administration should be done with meals to reduce possible stomach discomfort.

Adults (over 18 years):

The normal dose is 1 or 2 tablets up to 3 times a day, depending on the intensity of the pain, with a maximum of 6 tablets per day (750 mg of clonixine lysine per day).

Use in children and adolescents:

Do not use in children under 18 years of age without consulting a doctor.

Patient over 65 years:

Treatment will be used with caution, following the doctor's instructions.

Patient with kidney disease:

Treatment will be used with caution, following the doctor's instructions.

Patient with liver disease:

Treatment will be used with caution, following the doctor's instructions.

Administration of this medication is subject to the appearance of painful symptoms. As they disappear, the medication should be discontinued.

The duration of this treatment depends on the type of pain, intensity, and evolution of the disease. If the pain persists for more than 10 days or other symptoms appear, treatment should be discontinued and a doctor consulted.

If you take more Dolalgial than you should:

If the recommended doses are exceeded, headaches, dizziness, tremors, as well as abdominal pain, nausea, and vomiting may occur.

In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medication and the amount ingested.

In case of massive ingestion, stomach lavage and symptomatic treatment will be performed.

If you forget to take Dolalgial:

Do not take a double dose to make up for forgotten doses.

If you have any other doubts about the use of this medication, ask your doctor or pharmacist.

4. Possible side effects

Like all medications, this medication can cause side effects, although not everyone will experience them.

Frequent (may affect up to 1 in 10 people):

discomfort
stomach pain
nausea
vomiting
diarrhea
minimal intestinal bleeding.

Rare (may affect up to 1 in 1,000 people):

stomach inflammation
vomiting blood.

Very rare (may affect up to 1 in 10,000 people):

dizziness
hypersensitivity reactions (allergy) with skin rash and itching sensation.
eczema with spots
skin disorders.
blood disorders such as: agranulocytosis (decrease in white blood cells), anemia, or thrombocytopenia (decrease in platelet count)
bronchospasm (sudden feeling of suffocation)
breathing difficulties
insomnia
shortness of breath
tremors
pharyngitis
fever
fatigue
loss of appetite.

If you consider that any of the side effects you are experiencing is serious or if you notice any side effect not mentioned in this leaflet, inform your doctor or pharmacist.

Reporting side effects:

If you experience any type of side effect, consult your doctor, pharmacist, or nurse, even if it is a possible side effect not listed in this leaflet. You can also report them directly through the Spanish Medication Surveillance System for Human Use: www.notificaRAM.es

By reporting side effects, you can contribute to providing more information on the safety of this medication.

5. Storage of Dolalgial

Keep out of sight and reach of children.

Store in the original package to protect it from moisture and do not store above 30°C.

Do not use Dolalgial after the expiration date shown on the package after CAD. The expiration date is the last day of the month indicated.

Medications should not be disposed of through wastewater or household waste. Deposit the packages and medications you no longer need at the SIGRE point in the pharmacy. If in doubt, ask your pharmacist how to dispose of packages and medications you no longer need. This will help protect the environment.

6. Package contents and additional information

Composition of Dolalgial

The active ingredient is clonixine lysine. Each tablet contains 125 mg of clonixine lysine.

The other components are: pregelatinized cornstarch, microcrystalline cellulose, magnesium stearate, colloidal silicon dioxide, sepifilm 820 white (hypromellose, glycerol triacetate, titanium dioxide (E-171), and talc).

Appearance of the product and package contents

Dolalgial is a coated tablet, white, round, and has the letter "D" engraved on one side.

It is available in a package of 20 coated tablets in a blister pack.

Marketing authorization holder and manufacturer:

Holder:

Laboratory STADA, S.L.

Frederic Mompou, 5

08960 Sant Just Desvern

Spain

Manufacturer:

sanofi-aventis, S.A.

Ctra. La Batlloria a Hostalrich, km. 63,09

17404 - Riells i Viabrea (Girona)

Spain

Date of the last revision of this leaflet: December 2021

Detailed and updated information on this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques.

For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance.

Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults.

In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions.

Patients commonly seek his care for:

seasonal and perennial allergies
allergic rhinitis and chronic nasal symptoms
asthma and breathing difficulties
food and medication allergies
urticaria, atopic dermatitis and skin reactions
recurrent infections in children
sports-related health questions
general family medicine concerns

Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.

DOLALGIAL CLONIXINE LYSINE 125 mg FILM-COATED TABLETS

Iryna Reznychenko

Tomasz Grzelewski

Iryna Reznychenko

Tomasz Grzelewski